RIVO-Noord Zorgviewer Implementation Guide
1.16.0 - CI build
RIVO-Noord Zorgviewer Implementation Guide - Local Development build (v1.16.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2025-06-11 |
Mappings for the Condition resource profile.
No Mappings Found
No Mappings Found
Name | HCIM Problem-v4.1(2017EN) | HCIM BasicElements-v1.0(2017EN) | HCIM ConcernForTransfer-v3.0(2016EN) | HCIM ConcernForTransfer-v1.2(2015EN) | SNOMED CT Concept Domain Binding | HL7 v2 Mapping | RIM Mapping | W5 Mapping | SNOMED CT Attribute Binding![]() |
---|---|---|---|---|---|---|---|---|---|
![]() ![]() |
5.1.1 |
5.1.2 |
5.1.2 |
246090004 |Associated finding| =
((< 404684003 |Clinical finding| MINUS
<< 420134006 |Propensity to adverse reactions| MINUS
<< 473010000 |Hypersensitivity condition| MINUS
<< 79899007 |Drug interaction| MINUS
<< 69449002 |Drug action| MINUS
<< 441742003 |Evaluation finding| MINUS
<< 307824009 |Administrative status| MINUS
<< 385356007 |Tumor stage finding|) OR
< 272379006 |Event|) |
PPR message |
|
clinical.general |
||
![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() |
Act.text? |
||||||||
![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() |
0.0.6 |
.id |
id |
||||||
![]() ![]() ![]() |
5.1.4 |
5.1.4 |
5.1.4 |
< 303105007 |Disease phases| |
PRB-14 / DG1-6 |
|
status |
||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
5.1.4 |
5.1.4 |
5.1.4 |
N/A |
|||||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() |
5.1.10 |
< 410514004 |Finding context value| |
PRB-13 |
|
status |
408729009 | |||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() ![]() |
5.1.10 |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() |
5.1.8 |
5.1.8 |
5.1.8 |
< 404684003 |Clinical finding| |
'problem' if from PRB-3. 'diagnosis' if from DG1 segment in PV1 message |
.code |
class |
||
![]() ![]() ![]() |
< 272141005 |Severities| |
PRB-26 / ABS-3 |
|
grade |
246112005 | ||||
![]() ![]() ![]() |
5.1.3 |
5.1.3 |
5.1.3 |
code 246090004 |Associated finding| (< 404684003 |Clinical finding| MINUS
<< 420134006 |Propensity to adverse reactions| MINUS
<< 473010000 |Hypersensitivity condition| MINUS
<< 79899007 |Drug interaction| MINUS
<< 69449002 |Drug action| MINUS
<< 441742003 |Evaluation finding| MINUS
<< 307824009 |Administrative status| MINUS
<< 385356007 |Tumor stage finding|)
OR < 413350009 |Finding with explicit context|
OR < 272379006 |Event| |
PRB-3 |
.value |
what |
246090004 | |
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
|
|
|||||||
![]() ![]() ![]() ![]() |
C*E.9. But note many systems use C*E.2 for this |
./originalText[mediaType/code="text/plain"]/data |
|||||||
![]() ![]() ![]() |
5.1.11 |
< 442083009 |Anatomical or acquired body structure| |
.targetBodySiteCode |
363698007 | |||||
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
5.1.12 |
N/A |
|||||||
![]() ![]() ![]() ![]() |
|
|
|||||||
![]() ![]() ![]() ![]() |
C*E.9. But note many systems use C*E.2 for this |
./originalText[mediaType/code="text/plain"]/data |
|||||||
![]() ![]() ![]() |
0.0.11 |
PID-3 |
.participation[typeCode=SBJ].role[classCode=PAT] |
who.focus |
|||||
![]() ![]() ![]() |
PV1-19 (+PV1-54) |
|
context |
||||||
![]() ![]() ![]() |
PRB-16 |
|
when.init |
||||||
![]() ![]() ![]() ![]() |
5.1.6 |
0.0.14 |
5.1.6 |
5.1.6 |
PRB-16 |
|
when.init |
||
![]() ![]() ![]() |
|
when.done |
|||||||
![]() ![]() ![]() ![]() |
5.1.9 |
|
when.done |
||||||
![]() ![]() ![]() |
REL-11 |
.participation[typeCode=AUT].time |
when.recorded |
||||||
![]() ![]() ![]() |
0.0.2 |
REL-7.1 identifier + REL-7.12 type code |
.participation[typeCode=AUT].role |
who.author |
|||||
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
|||||||||
![]() ![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() |
.identifier |
||||||||
![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() |
|
||||||||
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() |
< 254291000 |Staging and scales| |
PRB-14 |
.value |
||||||
![]() ![]() ![]() ![]() |
.self |
||||||||
![]() ![]() ![]() |
|
||||||||
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
n/a |
||||||||
![]() ![]() ![]() ![]() |
N/A |
||||||||
![]() ![]() ![]() ![]() |
< 404684003 |Clinical finding| |
[code="diagnosis"].value |
why |
||||||
![]() ![]() ![]() ![]() |
.self |
why |
|||||||
![]() ![]() ![]() |
5.1.5 |
5.1.5 |
5.1.5 |
NTE child of PRB |
|
||||
![]() |